EUROPEAN TRAINING CENTRES
Gdansk - View

 

Medical University of Gdansk
Department of Nephrology Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland

 

HEAD OF THE UNIT Prof Boleslaw Rutkowski
CLINICAL STAFF Medical University Staff: Z. Zdrojewski, A. Debska-Slizien, A. Chamienia, B. Bullo, B. Biedunkiewicz, E. Król, L. Tylicki, M. Renke, M. Lichodziejewska-Niemierko, P. Rutkowski, S. Lizakowski, T. Liberek, W. Wolyniec

University Hospital Staff: D. Ogrodnik, G. Korejwo, J. Kowalewska, K. Wojnarowski, L. Chrobak, M. Chmielewski

PhD Students: B. Bzoma, J. Konopa, M. Przekwas, M. Myslicki

Postgraduate Students: G. Faran, M. Grabowska
RESEARCH STAFF W. Lysiak-Szydlowska, M. Jankowska, S. Malgorzewicz
 

 

CONTACT INFORMATION
E-MAIL bolo@amg.gda.pl
PHONE: +48-58-3492505
FAX: +48-58-3461186
FULL POSTAL ADDRESS Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Debinki 7, Gdansk 80-211, Poland
WEBSITE OF THE UNIT www.amg.gda.pl

 

CLINICAL FACILITIES
NEPHROLOGY BEDS N° 43  
HEMODIALYSIS PATIENTS N° 100
PERITONEAL DIALYSIS PATIENTS N° 75  
INTENSIVE CARE NEPHROLOGY BEDS N° 2  
RENAL TRANSPLANTS /YEAR (2002) N° 72  

 

RESEARCH INTERESTS

RESEARCH PROGRAMMES AND PROJECTS LIST
RESEARCH LIST

CLINICAL RESEARCH

RESEARCH PROGRAMMES AND PROJECTS LISTS
1. Epidemiology of chronic renal failure
2. Therapy of chronic glomerulonephritis
3. Renin-angiotensin system blockade as a nephroprtective strategy
4. Antioxidants: the possible role in kidney protection
5. Optimalisation of renal replacement therapy
6. Haematological, metabolic and immunomodulatory action of erythropoietin
7. The implication of ozonotherapy in nephrological patients


BASIC RESEARCH

RESEARCH PROGRAMMES AND PROJECT LIST
1. Carbohydrate and lipid metabolism disturbances in renal diseases
2. Uremic toxicity

 

Peer Reviewed Publications in International Journals (only English) 2000-2003

Publications list

1. Debska-Slizien A, Dudziak M, Kubasik A, Jackowiak D, Zdrojewski Z, Rutkowski B: Echocardiographic changes in left ventricular morphology and function after successful renal transplantation. Transplant Proc. 2000;32(6):1365-6.
2. Kisielnicka E, Zdrojewski Z, Wroblewska M, Kortas B, Rutkowski B. Lipid disturbances in a two-year follow-up after successful kidney transplantation. Transplant Proc 2000;32(6):1358-62.
3. Majkowicz M, Afeltowicz Z, Lichodziejewska-Niemierko M, Debska-Slizien A, Rutkowski B. Comparison of the quality of life in hemodialysed (HD) and peritoneally dialysed (CAPD) patients using the EORTC QLQ-C30 questionnaire. Int J Artif Organs 2000;23(7):423-8.
4. Debska-Slizien, Kawecka A, Wojnarowski K, Prajs J, Malgorzewicz S, Kunicka D, Zdrojewski Z, Walysiak-Szydlowska, Lipinski J, Rutkowski B. Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients. Int J Artif Organs 2000;23(2):90-6.
5. Rutkowski B. Changing pattern of end-stage renal disease in central and eastern Europe. Nephrol Dial Transplant 2000;15(2):156-60.
6. Marlewski M, Szolkiewicz M, Smolenski RT, Manitius J, Rutkowski B, Swierczynski J. Different effects of chronic renal failure on erythrocyte nucleotide concentrations in humans and rats. Nephron 2000;84(1):92-4.
7. Marlewski M, Smolenski RT, Szolkiewicz M, Aleksandrowicz Z, Rutkowski B, Swierczynski J. Accelerated degradation of adenine nucleotide in erythrocytes of patients with chronic renal failure. Mol Cell Biochem 2000;213(1-2):93-7.
8. Marlewski M, Smolenski RT, Szolkiewicz M, Aleksandrowicz Z, Rutkowski B, Swierczynski J. Increased rate of adenine incorporation into adenine nucleotide pool in erythrocytes of patients with chronic renal failure. Nephron 2000 Nov;86(3):281-6.
9. Kisielnicka E, Zdrojewski Z, Wroblewska M, Kortas B, Lysiak-Szydlowska W, Rutkowski B. Does immunosuppressive regimen influence the lipid disturbances in kidney recipients? Am J Nephrol 2000; 20(5):385-90.
10. Korczynska J, Stelmanska E, Nieweglowski T, Szolkiewicz M, Rutkowski B, Swierczynski J. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
11. Swierczynski J, Korczynska J, Szolkiewicz M, Karbowska J, Kochan Z, Nieweglowski T, Kusiak E, Rutkowski B. Low leptin mRNA level in adipose tissue and normoleptinemia in experimental chronic renal failure. Exp Nephrol 2001;9(1):54-9.
12. Tylicki L, Niew glowski T, Biedunkiewicz B, Burakowski S, Rutkowski B. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study. Int J Artif Organs 2001;24(2):79-82.
13. Kokot F, Lysiak-Szydlowska W, Adamczak M, Chudek J, Ignacy W, Rutkowski B, Ficek R, Wiecek A. Are plasma concentrations of leptin and carnitine interrelated in haemodialysis patients? Nephrol Dial Transplant. 2001;16(2):434-5
14. Chmielewski M, Nieweglowski T, Swierczynski J, Rutkowski B, Boguslawski W. Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure. Mol Cell Biochem 2001;228(1-2):33-7.
15. Szolkiewicz M, Kochan Z, Swierczynski J, Rutkowski B. Lipogenesis in experimental chronic renal failure in rats. Ren Fail 2001 ; 23(5):621-8.
16. Renke M, Zegrzda D, Liberek T, Dudziak M, Lichodziejewska-Niemierko M, Kubasik A, Rutkowski B. Interrelationship between cardiac structure and function and incidence of arrhythmia in peritoneal dialysis patients. Int J Artif Organs 2001;24(6):374-9.
17. Locatelli F, Rutkowski B, Andrulli S, Enia G, Gellert R, Kramar R, Marcelli D, Zoccali C, Wiecek A, Ritz E. Gdansk bio-statistic and epidemiology course. Nephrol Dial Transplant 2001;16(8):1559-61.
18. Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradsky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Nagy KK, Hickey D. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients. Ann Transplant 2002;7(3):28-31.
19. Krol E, Myslicki M, Rutkowski P, Rutkowski B. Increased cardiac troponin T is linked to the type of renal replacement therapy. Am J Kidney Dis 2002;40(6):1350-1
20. Chmielewski M, Zdrojewski Z, Rutkowski B. Benefits and menaces related to the use of statins in patients after renal transplantation. Ann Transplant. 2002;7(2):6-10
21. Zdrojewski Z, Lizakowski S, Raszeja-Specht A, Skibowska A, Rutkowski B. Influence of spontaneous platelet aggregation on progression of glomerular disease. Nephron 2002;92(1):36-42.
22. Tylicki L, Rutkowski P, Renke M, Rutkowski B. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation. Am J Nephrol. 2002;22(4):356-62.
23. Szolkiewicz M, Sucajtys E, Chmielewski M, Wolyniec W, Rutkowski P, Boguslawski W, Swierczynski J, Rutkowski B. Increased rate of cholesterologenesis--a possible cause of hypercholesterolemia in experimental chronic renal failure in rats. Horm Metab Res 2002; 34(5):234-7.
24. Slominska EM, Szolkiewicz M, Smolenski RT, Rutkowski B, Swierczynski J. High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP. Nephron. 2002;91(2):286-91.
25. Trzonkowski P, Mysliwska J, Debska-Slizien A, Bryl E, Rachon D, Mysliwski A, Rutkowski B. Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients. Nephrol Dial Transplant. 2002;17(6):1070-80.
26. Korejwo G, Hermann A, Zdrojewski Z, Debska-Slizien A, Rutkowski B. Improved autonomic function after kidney transplantation. Transplant Proc. 2002 Mar;34(2):601-3
27. Wolyniec W, Debska-Slizien A, Chamienia A, Ignacy Pirski M, Lysiak-Szydlowska W, Sledzinski Z, Rutkowski B. Cyclosporine A-related hemolytic uremic syndrome after living renal transplantation-case report. Transplant Proc 2002;34(2):569-71
28. Tylicki L, Renke M, Rutkowski P, Rutkowski B. Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study. J Ren Nutr 2002;12(2):122-5.
29. Slominska EM, Smolenski RT, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds HA, Swierczynski J. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem 2002;231(1-2):83-8.
30. Liberek T, Lichodziejewska-Niemierko M, Kowalewska J, Swiatkowska-Freund M, Rutkowski B. Uterine prolapse--a rare or rarely reported complication of CAPD? Perit Dial Int 2002;22(1):95-6.
31. Lichodziejewska-Niemierko M, Afeltowicz Z, Majkowicz M, Debska-Slizien A, Rutkowski B. High level of negative emotions in hemodialysis patients suggests the need for therapy. Nephron 2002;90(3):355-6
32. Szolkiewicz M, Nieweglowski T, Korczynska J, Sucajtys E, Stelmanska E, Goyke E, Swierczynski J, Rutkowski B. Upregulation of fatty acid synthase gene expression in experimental chronic renal failure. Metabolism 2002;51(12):1605-10.
33. Liberek T, Lichodziejewska-Niemierko M, Knopinska-Posluszny W, Schaub TP, Kirchgessner J, Passlick-Deetjen J, Rutkowski B. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid. Perit Dial Int 2002;22(6):663-9.
34. Tylicki L, Rutkowski B, Horl WH. Multifactorial determination of hypertensive nephroangiosclerosis. Kidney Blood Press Res. 2002;25(6):341-53.
35. Debska-Slizien A, Chamienia A, Krol E, Zdrojewski Z, Pirski I, Zadrozny D, Sledzinski Z, Rutkowski B. Hemolytic anemia after renal transplantation: analysis of case reports. Transplant Proc. 2003 ; 35(6):2233-7.
36. Przekwas M, Malgorzewicz S, Zdrojewski Z, Debska-Slizien A, Lysiak-Szydlowska W, Rutkowski B. Influence of predialysis oxidative stress on peroxidation processes after renal transplantation. Transplant Proc. 2003;35(6):2170-3.
37. Bullo B, Zdrojewski Z, Rutkowski B. Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN). Kidney Int 2003;64(3):1139
38. Chmielewski M, Sucajtys E, Swierczynski J, Rutkowski B, Boguslawski W. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure. Mol Cell Biochem. 2003;246(1-2):187-91.
39. Biedunkiewicz B, Tylicki L, Lichodziejewska-Niemierko M, Liberek T, Rutkowski B. Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy. Kidney Int. 2003;64(1):367-8.
40. Tylicki L, Nieweglowski T, Biedunkiewicz B, Chamienia A, Debska-Slizien A, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs. Int J Artif Organs 2003;26(4):297-303.
41. Tylicki L, Manitius J, Lysiak-Szydlowska W, Rutkowski B. Tubular injury: the first symptom of hypertensive kidney involvement? Med Sci Monit. 2003;9(4):CR135-41.
42. Rutkowski B, Slominska E, Szolkiewicz M, Smolenski RT, Striley C, Rutkowski P, Swierczynski J. N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin? Kidney Int Suppl 2003;(84):S19-21.
43. Liberek T, Chmielewski M, Lichodziejewska-Niemierko M, Renke M, Zadrozny D, Rutkowski B. Survival and function of Tenckhoff peritoneal dialysis catheter after surgical or percutaneous placement: one centre experience. Int J Artif Organs 2003;26(2):174-5. No abstract available.
44. Wasilewska A, Narkiewicz M, Rutkowski B, Lysiak-Szydlowska W. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis? Med Sci Monit 2003;9(3):CR147-51.
45. Rutkowski B, Szolkiewicz M, Korczynska J, Sucajtys E, Stelmanska E, Nieweglowski T, Swierczynski J. The role of lipogenesis in the development of uremic hyperlipidemia. Am J Kidney Dis 2003;41(3 Suppl 1):S84-8.
46. Debska-Slizien A, Owczarzak A, Kunicka D, Lysiak-Szydlowska W, Rutkowski B. Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietin. Int J Artif Organs 2003;26(1):33-8.




European Fellows programme

Specify if the Unit accepts fellows from European countries for:
Short (1-2 month) well focused training programs either clinically or laboratory oriented: Yes.
Long (at least 1 year) research fellowships: Yes.
Specify corresponding availability of grants: Yes. Possibility of the application for grants from Polish Governmental Committee for Scientific Research.
Specify if the Unit may provide help for accommodation: Yes (limited).

Prerequisites for Fellowship

Language: English, Polish

Work/Research experience: graduate of medical faculty, basic experience in clinical nephrology and laboratory work